Novartis AG (NVSN) — Cash Flow-to-Debt Ratio
Novartis AG (NVSN) has a Cash Flow-to-Debt Ratio of 0.05x as of March 2026, meaning its operating cash flow of MX$3.68 Billion could theoretically repay 0% of its total liabilities (MX$79.61 Billion) in one year. Explore long-term investment intensity of Novartis AG to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Novartis AG Cash Flow-to-Debt Ratio (2014–2025)
Historical debt coverage capacity for Novartis AG across 12 annual periods. Also explore Novartis AG assets under control for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Novartis AG (2014–2025)
Year-by-year debt coverage analysis for Novartis AG. For market capitalisation and broader financial context, see NVSN market cap overview.
| Year | CF-to-Debt Ratio | Operating CF (MXN) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.30x | MX$19.14 Billion | MX$64.40 Billion | ▼ -1.9% |
| 2024 | 0.30x | MX$17.62 Billion | MX$58.12 Billion | ▲ +0.6% |
| 2023 | 0.30x | MX$16.02 Billion | MX$53.20 Billion | ▲ +22.8% |
| 2022 | 0.25x | MX$14.24 Billion | MX$58.03 Billion | ▲ +4.1% |
| 2021 | 0.24x | MX$15.07 Billion | MX$63.97 Billion | ▲ +30.1% |
| 2020 | 0.18x | MX$13.65 Billion | MX$75.39 Billion | ▼ -16.5% |
| 2019 | 0.22x | MX$13.62 Billion | MX$62.82 Billion | ▲ +1.6% |
| 2018 | 0.21x | MX$14.27 Billion | MX$66.87 Billion | ▼ -0.5% |
| 2017 | 0.21x | MX$12.62 Billion | MX$58.85 Billion | ▲ +3.2% |
| 2016 | 0.21x | MX$11.47 Billion | MX$55.23 Billion | ▼ -4.9% |
| 2015 | 0.22x | MX$11.90 Billion | MX$54.43 Billion | ▼ -14.2% |
| 2014 | 0.25x | MX$13.90 Billion | MX$54.54 Billion | — |